# A Phase III Second Line Trial in Advanced Pancreatic Cancer CONKO 003

> **NCT00786058** · — · APPROVED_FOR_MARKETING · sponsor: **CONKO-Studiengruppe**

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** OFF in experimental arm

## Key facts

- **NCT ID:** NCT00786058
- **Lead sponsor:** CONKO-Studiengruppe
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** APPROVED_FOR_MARKETING
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2009-06-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00786058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00786058, "A Phase III Second Line Trial in Advanced Pancreatic Cancer CONKO 003". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00786058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*